Navigation Links
Penn Pharma Invests In World-Class Inventory Management System
Date:1/11/2010

PHILADELPHIA, Jan. 11 /PRNewswire/ -- Global integrated pharmaceutical manufacturer, Penn Pharma, has invested more than $566,000 in a state-of-the-art inventory management system - incorporating real time bar coding control, unprecedented levels of stock accuracy and the Penn Customer Portal. This system makes Penn Pharma one of the first companies in its class in the U.S. or Europe to provide customers with an all-encompassing, remote access global product and inventory tracking service.

"As a business, we have a large worldwide market presence, particularly in the U.S. and Japan. Our investment in this new Customer Portal not only increases product visibility for customers wishing to track their order status, materials disposition and third party shipping but also further enables Penn Pharma to compete on the global stage as a standard for best practices," said Darren Hassey, chief operating officer at Penn Pharma.

The main driver behind this investment is to make the processes within Penn Pharma completely transparent for its customers so that the company becomes a client partner rather than a supplier, providing support every step of the way.

The new Penn Customer Portal is completely secure and allows customers to remotely access and track their Penn Pharma product inventory and also materials in transit to the end destination, whether it be an investigator site or customer storage facility. The Portal provides access to real time inventory information concerning excipients, Active Pharmaceutical Ingredients,(API) packaging materials and finished products/clinical packs, 24-hours-a-day, 365-days-a-year.

Innovative links with third party shipping websites also allow customers to view dispatch information via the Portal to enable tracking of materials and finished products across the supply chain.

"Our new Customer Portal system has been fully validated by an independent specialist making us the first company in Europe, if not the world, to validate this Sage 500 ERP software package to further enhance the quality of service and compliance we provide for our customers as part of our suite of integrated formulation, analytical services, clinical trials supply and clinical / commercial manufacturing solutions," said Hassey.

About Penn Pharma

Penn Pharma is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international healthcare industry, whose services support a fast and effective route from clinic to market. Penn Pharma provides unparalleled service offerings developed over its 30 year trading history. Penn Pharma has offices in South Wales, the UK and the U.S. www.pennpharm.com


    PR Contact:            Corporate Contact:
    Judith Eckles          Britton Jimenez
    484-684-6717           925-787-6886
    judithe@sagefrog.com   Britton.Jimenez@Pennpharm.com
    Sagefrog Marketing     Penn Pharma

SOURCE Penn Pharma

RELATED LINKS
http://www.pennpharm.com

'/>"/>

SOURCE Penn Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , ... April 28, 2016 , ... Head Over Heels ... 9 Western Championships. The competition will be held at the University of Montana on ... gymnasts west of the Mississippi River. , In order to qualify, Varize needed to ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... open availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. ... This innovative standard will make it possible to build applications that generate ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online ... cosmetictown.com . The forum section was recently revamped and upgraded to allow even more ... in use across the country. , According to the senior editor of Cosmetic Town, ...
(Date:4/28/2016)... ... 2016 , ... Greener Hydroponics is now offering a large selection of Smart ... organic farmers and nurseries according to Sales Manager Joe Steele who says, “Now is ... is to offer wholesale level pricing and ultra-fast shipping for growers of any size.” ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
(Date:4/27/2016)... 2016 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends, and ... global skincare devices market was valued at US$ 7,255.8 ... a CAGR of 10.1% from 2015 to 2023 to ... the full Skincare Devices Market (Treatment Device - LED Therapy ...
Breaking Medicine Technology: